PFO Closure Device Approved by FDA to Prevent Recurrent Strokes

Short resume:

patients
90%
cause
80%
blood
60%
heart
50%
PFO Closure Device Approved by FDA to Prevent Recurrent Strokes

HealthDay News – The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among patients who have had at least one prior stroke involving a patent foramen ovale (PFO).
Source Monthly Prescribing Reference (registration)
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*